Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-05-10 Purchase | 2024-05-13 08:49 am | Nuvectis Pharma Inc. | NVCT | Poradosu Enrique Chief Science & Business Off | 500 | $6.29 | $3,145 | 1,504,319 (Direct) | View |
| 2023-03-27 Purchase | 2023-03-28 08:30 am | Nuvectis Pharma Inc. | NVCT | Poradosu Enrique Chief Science & Business Off | 500 | $11.55 | $5,775 | 1,373,819 (Direct) | View |
| 2022-05-12 Purchase | 2022-05-16 08:31 am | Nuvectis Pharma Inc. | NVCT | Poradosu Enrique Chief Science & Business Off | 670 | $15.33 | $10,273 | 1,258,319 (Direct) | View |
| 2022-02-04 Purchase | 2022-02-08 6:01 pm | Nuvectis Pharma Inc. | NVCT | Poradosu Enrique Chief Science & Business Off | 4,600 | $3.4422 | $15,834 | 1,197,649 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-03 Option Award | 2024-01-05 4:31 pm | N/A N/A | Nuvectis Pharma Inc. | NVCT | Poradosu Enrique Chief Science & Business Off | 130,000 | $0 | 1,503,819 (Direct) | View |
| 2023-01-12 Option Award | 2023-01-13 5:05 pm | N/A N/A | Nuvectis Pharma Inc. | NVCT | Poradosu Enrique Chief Science & Business Off | 115,000 | $0 | 1,373,319 (Direct) | View |
| 2022-04-01 Option Award | 2022-04-05 4:46 pm | N/A N/A | Nuvectis Pharma Inc. | NVCT | Poradosu Enrique Chief Science & Business Off | 60,000 | $0 | 1,257,649 (Direct) | View |
Ownership | 2022-02-08 08:26 am | N/A N/A | Nuvectis Pharma Inc. | NVCT | Poradosu Enrique Chief Science and Business Off | 0 | $0 | 1,193,049 (Direct) | View |